...
首页> 外文期刊>Scientific reports. >Weighted Multi-marker Genetic Risk Scores for Incident Coronary Heart Disease among Individuals of African, Latino and East-Asian Ancestry
【24h】

Weighted Multi-marker Genetic Risk Scores for Incident Coronary Heart Disease among Individuals of African, Latino and East-Asian Ancestry

机译:非洲人,拉丁裔和东亚血统个人中发生冠心病的加权多标记遗传风险评分

获取原文
   

获取外文期刊封面封底 >>

       

摘要

We examined the clinical utility of two multi-locus genetic risk scores (GRSs) previously validated in Europeans among persons of African (AFR; n?=?2,089), Latino (LAT; n?=?4,349) and East-Asian (EA; n?=?4,804) ancestry. We used data from the GERA cohort (30–79 years old, 68 to 73% female). We utilized two GRSs with 12 and 51 SNPs, respectively, and the Framingham Risk Score (FRS) to estimate 10-year CHD risk. After a median 8.7 years of follow-up, 450 incident CHD events were documented (95 in AFR, 316 in LAT and 39 EA, respectively). In a model adjusting for principal components and risk factors, tertile 3 vs. tertile 1 of GRS_12 was associated with 1.86 (95% CI, 1.15–3.01), 1.52 (95% CI, 1.02–2.25) and 1.19 (95% CI, 0.77–1.83) increased hazard of CHD in AFR, LAT and EA, respectively. Inclusion of the GRSs in models containing the FRS did not increase the C-statistic but resulted in net overall reclassification of 10% of AFR, 7% LAT and EA and in reclassification of 13% of AFR and EA as well as 10% LAT in the intermediate FRS risk subset. Our results support the usefulness of incorporating genetic information into risk assessment for primary prevention among minority subjects in the U.S.
机译:我们检查了两种多基因座遗传风险评分(GRS)的临床效用,以前在非洲人(AFR; N?= 2,089),拉丁裔(LAT; N?=?4,349)和东亚(EA ; n?=?4,804)祖先。我们使用来自Gera Cohort的数据(30-79岁,女性68至73%)。我们分别利用了两个带有12和51个SNP的GRS,以及FRAMINGHAM风险评分(FRS)来估算10年的CHD风险。在中位后的8.7年后续后,记录了450个事件CHD事件(AFR,LAT 316的95,分别为39 ea)。在针对主成分和风险因素的模型中,GRS_12的Tertile 3与Zertile1有关1.86(95%CI,1.15-3.01),1.52(95%CI,1.02-25)和1.19(95%CI, 0.77-1.83)分别增加了AFR,LAT和EA中CHD的危害。将GRS包含在含FRS的模型中没有增加C统计,但导致10%的AFR,7%LAT和EA的净整体重新分类,并重新分类13%的AFR和EA以及10%LAT中间FRS风险子集。我们的业绩支持将遗传信息纳入风险评估的有用性,以便在美国少数群体受试者中预防初步预防。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号